航天彩虹(002389.SZ):目前彩虹7、彩虹10項目研發工作正常推進中
格隆匯5月25日丨有投資者在投資者互動平台向航天彩虹(002389.SZ)提問,“公司彩虹7、彩虹10現在是什麼進展? 彩虹8、彩虹9是預留型號嗎?”
航天彩虹(002389.SZ)回覆稱,彩虹7、彩虹10等產品的研製速度與用户對於裝備的技術指標、可靠性、穩定性等綜合性能不斷迭代提升的情況相關,另外,定型量產的時間也與客户的需求節奏密切相關。目前,彩虹7、彩虹10項目研發工作正常推進中,公司也在積極對接用户,加快產品研製和後續產品化進程。彩虹8系列主要為輕型固定翼無人機、旋翼機等,彩虹9目前尚無相關型號產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.